Form 8-K CYTOKINETICS INC For: Dec 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cytokinetics (CYTK) PT Raised to $48 at JMP Securities
December 20, 2021 2:05 PM ESTJMP Securities analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $48.00 (from $44.00) while maintaining a Market Outperform rating on the expanding Ji Xing cardiovascular partnership.
... More